General Counsel and Head of Compliance @ (May 2025 - April 2026)
Chief Business Development and Legal Officer @ (July 2024 - January 2026)
Chief Business and Legal Officer @ (June 2022 - October 2023)
General Counsel @ Pharmacosmos Therapeutics (October 2020 - June 2022)
General Counsel and Head of Business Development @ (November 2019 - October 2020)
Vice President and Head of GI Business Development, Externalization, and Special Projects @ (December 2018 - November 2019)
Assistant General Counsel - Established Products and Essential Health Business Unit @ (August 2001 - December 2018)
Summer Law Clerk @ (May 2001 - August 2002)
Sr. QA Administrator @ (January 1999 - January 2000)
Clinical Research Associate @ Syneos Health, fka PharmaNet (January 1997 - January 1999)
Medical Research Associate @ Target Research Associates (January 1996 - January 1997)
Chief Business Development and Legal Officer @ (July 2024 - May 2025)
Chris Slavinsky Education
Washington University in St. Louis School of Law
JD (Law)
2000-2003
Thomas Jefferson University
MS (Biochemistry)
1993-1997
Stony Brook University
BS (Biochemistry)
1991-1993
Chris Slavinsky Summary
Chris Slavinsky, based in United States, is currently a Chief Business Officer at Theradaptive. Chris Slavinsky brings experience from previous roles at CSM Advisors, Innovo Research, Corstasis Therapeutics and HanAll Biopharma. Chris Slavinsky holds a 2000 - 2003 JD in Law @ Washington University in St. Louis School of Law. Chris Slavinsky has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Chris Slavinsky?
Find contact details for 700 million professionals.